News

ASX
LCT 0.041   Last updated EOD 10th December 2018
Fact sheet
The following fact sheets provide a summary of our current business and research pipeline.
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.

Fact sheet

save-icon

CEO's presentation to the AGM

— 14 November 2018

save-icon

CEO's presentation to the AGM

— 15 November 2017

save-icon

Investor call: NTCELL Phase IIb study findings

Listen to CEO Dr Ken Taylor and Principal Invesigator Dr Barry Snow discuss the top-line results of the Phase IIb study of NTCELL in Parkinson's disease.

— 10 November 2017

Load More
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.